Evaluation the Effects of Various Treatments on RZL-012-Induced Adverse Events
Clinical trial NCT05476679 · COMPLETED
Trial details
- NCT number
- NCT05476679
- Sponsor
- Raziel Therapeutics Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-25
- Primary completion
- 2023-06-12
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.